XN has been shown to suppress the growth of various cancer cell lines, including breast, colon, prostate, and liver cancers, by modulating key signaling pathways such as NF-κB and PI3K/Akt/mTOR [122]. The gene discussed is AKT1; the disease is liver cancer.